Our latest WormGazer™ videos and Case Studies

The technology developed by Magnitude Biosciences images the movement of worms on several petri dishes at once. On the right you can see a control dish with a single C. elegans worm and another with a worm exposed to the acaricide etoxazole. The white tracks show the movement of the worms, that are the progeny of the original animal.
You will see that in the presence of etoxazole, there are far fewer worms. The graph on the left shows the increase in worm population over time as the experiment progresses. Increasing doses of etoxazole reduce the population size. The bar graph compares the area under the curves to give a quantitative measure of reproductive toxicity. This dataset can be further analysed to measure the rate of population growth and reveal delays in the onset of egg-laying.

Ageing is a complex and heterogeneous process and is best studied using natural models of ageing in whole organisms and large test populations. C. elegans is a proven model in many fields of biology including ageing, where major breakthroughs have occurred by identifying mutants and interventions that increase lifespan.
To evaluate and develop therapies that delay ageing or degenerative disease, we need to measure their effect on physiological decline in an ageing model. The nematode worm C. elegans slows down within days of reaching adulthood and this video shows an automated method to quantify that decline developed by Magnitude Biosciences.
The automated technology continually monitors large numbers of C. elegans worms without disturbing them, working out how many worms on each of several petri dishes are moving during a 160 second interval every 5 minutes. In this video, you can see the movement of a wild type C. elegans strain and a strain that has been modified to express the human amyloid peptide (Aβ 1-42) as a model for Alzheimer’s disease.
On the right, you can see the movement of worms on two of many petri dishes on which the worms are cultured. The white tracks are the current movement of the worms, the red colour indicates past movement. You can clearly see more movement with the wild type strain compared to the Alzheimer’s disease model.
One the left is a graph of the proportion of worms moving in the population with time. You can see that a smaller proportion of the disease worms are moving from the beginning and their movement declines quickly with time. For the wild type strain, movement peaks around day 2 and then starts to decline but much more slowly than the disease model worms.
The difference between these strains can be quantified by comparing the area under the curves as shown in the bar graph, which shows how long the average worm stays moving, a measure of healthspan.
GeroState Alpha is a pharmaceutical company, based at the Buck Institute for Research on Ageing in Novato, California, US. Their key therapeutic focus is on treating ageing and age-related disease.
They needed to test their lead compounds to establish which was most effective at promoting health and slowing ageing.
Magnitude Biosciences worked with Gerostate Alpha to help the pharmaceutical company prioritise their small molecule candidate pipeline for their effects to delay ageing.
For more information about how we could help you understand the effects and mechanism of your compound click here.
Magnitude Biosciences CEO, David Weinkove, discusses the application of C. elegans to accelerate the industrial drug discovery process at ELRIG and the British Pharmacological Society's event Translating Ideas Into Therapies 2021. You can also read our blog post summarising key takeaways from the other talks at the event:
https://magnitudebiosciences.com/2021/07/09/elrig-bps-meeting-2021/
Contact us if you'd like to find out if and how we can help you with your drug discovery research
Sign up to our newsletter today, to get access to the latest company and industry news
© 2025 Magnitude Biosciences Ltd. All rights reserved.